Cargando…
Bioflavonoid Galangin Suppresses Hypertrophic Scar Formation by the TGF-β/Smad Signaling Pathway
BACKGROUND: Hypertrophic scar (HS) is a benign fibroproliferative skin disease resulting from an aberrant wound healing process and can cause aesthetic and functional damage to patients. Currently, there is no ideal treatment to treat this disease. Galangin, a natural active bioflavonoid compound, i...
Autores principales: | Ru, Zha, Hu, Ying, Huang, Shenghua, Bai, Li, Zhang, Kun, Li, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434902/ https://www.ncbi.nlm.nih.gov/pubmed/34518767 http://dx.doi.org/10.1155/2021/2444839 |
Ejemplares similares
-
Emodin alleviates hypertrophic scar formation by suppressing macrophage polarization and inhibiting the Notch and TGF-β pathways in macrophages
por: Xia, Zihuan, et al.
Publicado: (2021) -
Effect of artesunate and relation with TGF-β1 and SMAD3 signaling on experimental hypertrophic scar model in rabbit ear
por: Nong, Xiaolin, et al.
Publicado: (2019) -
Gallic Acid Treats Hypertrophic Scar in Rabbit Ears via the TGF-β/Smad and TRPC3 Signaling Pathways
por: Li, Qiannan, et al.
Publicado: (2023) -
The compound losartan cream inhibits scar formation via TGF-β/Smad pathway
por: Zhao, Wan-Yi, et al.
Publicado: (2022) -
Inhibition of sphingosine kinase 2 attenuates hypertrophic scar formation via upregulation of Smad7 in human hypertrophic scar fibroblasts
por: Zeng, Jian, et al.
Publicado: (2020)